Transarterial Infusion Chemotherapy Using Cisplatin-Lipiodol Suspension With or Without Embolization for Unresectable Hepatocellular Carcinoma
CardioVascular and Interventional Radiology 32 巻 4 号
687-694 頁
2009-05-15 発行
アクセス数 : 1041 件
ダウンロード数 : 298 件
今月のアクセス数 : 0 件
今月のダウンロード数 : 0 件
この文献の参照には次のURLをご利用ください : https://ir.lib.hiroshima-u.ac.jp/00028886
ファイル情報(添付) | |
タイトル ( eng ) |
Transarterial Infusion Chemotherapy Using Cisplatin-Lipiodol Suspension With or Without Embolization for Unresectable Hepatocellular Carcinoma
|
作成者 |
Takaki Shintaro
Katamura Yoshio
Waki Koji
Takahashi Shoichi
Hieda Masashi
Toyota Naoyuki
Ito Katsuhide
|
収録物名 |
CardioVascular and Interventional Radiology
|
巻 | 32 |
号 | 4 |
開始ページ | 687 |
終了ページ | 694 |
抄録 |
We evaluate the long-term prognosis and prognostic factors in patients treated with transarterial infusion chemotherapy using cisplatin-lipiodol (CDDP/LPD) suspension with or without embolization for unresectable hepatocellular carcinoma (HCC). Study subjects were 107 patients with HCC treated with repeated transarterial infusion chemotherapy alone using CDDP/LPD (adjusted as CDDP 10mg/LPD 1ml). The median number of transarterial infusion procedures was two (range, one to nine), the mean dose of CDDP per transarterial infusion chemotherapy session was 30 mg (range, 5.0–67.5 mg), and the median total dose of transarterial infusion chemotherapy per patient was 60 mg (range, 10–390 mg). Survival rates were 86-0x1.fc400000008p+0t 1 year, 40 0x1.c617665206557p+855t 3 years, 20 0x1.5687420657461p-505t 5 years, and 16 0x1.5742d676e6f6cp+807t 7 years. For patients with >90% PD accumulation after the first transarterial infusion chemotherapy, rates were 98 0x1.e676f7270206dp+759t 1 year, 60 0x1.46e6120736973p-505t 3 years, and 22 0x1.36f6e676f727p+840t 5 years. Multivariate analysis identified >90% PD accumulation after the first transarterial infusion chemotherapy (p = 0.001), absence of portal vein tumor thrombosis (PVTT; p < 0.001), and Child-Pugh class A (p = 0.012) as independent determinants of survival. Anaphylactic shock was observed in two patients, at the fifth transarterial infusion chemotherapy session in one and the ninth in the other. In conclusion, transarterial infusion chemotherapy with CDDP/LPD appears to be a useful treatment option for patients with unresectable HCC without PVTT and in Child-Pugh class A. LPD accumulation after the first transarterial infusion chemotherapy is an important prognostic factor. Careful consideration should be given to the possibility of anaphylactic shock upon repeat infusion with CDDP/LPD.
|
著者キーワード |
Hepatocellular carcinoma
Transcatheter arterial chemoembolization
Cisplatin
lipiodol suspension
Arterial infusion chemotherapy
Prognosis
|
NDC分類 |
医学 [ 490 ]
|
言語 |
英語
|
資源タイプ | 学術雑誌論文 |
出版者 |
Springer New York
|
発行日 | 2009-05-15 |
権利情報 |
Copyright (c) 2009 Springer
|
出版タイプ | Author’s Original(十分な品質であるとして、著者から正式な査読に提出される版) |
アクセス権 | オープンアクセス |
収録物識別子 |
The original publication is available at www.springerlink.com
[ISSN] 0174-1551
[DOI] 10.1007/s00270-009-9570-2
[NCID] AA00141846
[DOI] http://dx.doi.org/10.1007/s00270-009-9570-2
|